Kraig Biocraft Laboratories (KBLB) Liabilities and Shareholders Equity (2010 - 2026)

Kraig Biocraft Laboratories has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $2.6 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity rose 70.43% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (down 8.15% YoY) and the FY2025 annual result came in at $2.6 million, up 70.43% from the prior year.
• Liabilities and Shareholders Equity improved to $2.6 million in Q4 2025 per KBLB's latest filing, from $2.4 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $5.4 million in Q2 2022 and troughed at $1.3 million in Q1 2025.
• A 5-year average of $3.1 million and a median of $3.1 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2021 and 2024: Liabilities and Shareholders Equity jumped 597.07% in 2021, then plunged 53.44% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $3.0 million in 2021, then soared by 51.26% to $4.6 million in 2022, then dropped by 29.27% to $3.2 million in 2023, then sank by 53.44% to $1.5 million in 2024, then surged by 70.43% to $2.6 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.6 million, $2.4 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.